Recent studies have shown that blocking the METTL1-TGF-β2-PMN-MDSC axis can reduce the recurrence of HCC, further highlighting the importance of METTL1/WDR4 in HCC progression. The gene discussed is METTL1; the disease is hepatocellular carcinoma.